股东起诉Viatris在印度设施涉嫌与林业发展局问题有关的欺诈。 Shareholders sue Viatris over alleged fraud linked to FDA issues at its India facility.

对Viatris Inc.提起了集体诉讼,目的是为2024年8月8日至2025年2月26日期间受据称证券欺诈影响的股东追回损失。 A class-action lawsuit has been filed against Viatris Inc., aiming to recover losses for shareholders affected by alleged securities fraud from August 8, 2024, to February 26, 2025. 诉讼声称Viatris误导投资者对印度印多尔工厂的问题, 包括FDA检查和警告信失败, The lawsuit claims Viatris misled investors about issues at its Indore, India facility, including a failed FDA inspection and warning letter, which led to a 15% drop in stock prices after the company issued disappointing financial guidance. 遭受损失的股东可通过与Levi & Korsinsky联系寻求补偿。 Shareholders who suffered losses can seek recovery by contacting Levi & Korsinsky.